RSSThemes: Biotechnology and Pharma From 30,000 Feet
- Christoph Hergersberg Discusses R&D Strategy Within Pharmas
- Christoph Hergersberg States Reality of Huge Knowledge Base Within Pharma Companies
- Christoph Hergersberg Discusses Relationship Between Big Pharmas and Small Biotech Companies
- Saurabh Saha Discusses Current State Of Pharmaceutical Industry
- Bryan Pearce Provides Overview of VC Funding Environment Within Biotech Sector
- Bryan Pearce Discusses Where New VC Money Is Going Within Biotech Sector
- Bryan Pearce Shares Thoughts on How Much Money A Biotech Startup Should Raise
- Bryan Pearce Outlines VC Exit Strategy For Biotech Firms In 2005
- Bryan Pearce Discusses Average Duration of VC Investment In Biotech Companies Before Exit
- Bryan Pearce States M&A Activity Within Biotech Sector Has Increased
- Bryan Pearce Discusses Reasons For Aligning With Partner
- Bryan Pearce Discusses Sources of Initial Funding For Biotech Startups
- Bryan Pearce Discusses Alternative Sources of Funding For Biotech Startups
- Richard Ramko Provides Brief Overview of Global Biotechnology Industry
- Richard Ramko Discusses The Merck Biotech Index
- Richard Ramko Discusses Financing Within The Biotech Sector
- Richard Ramko Discusses Biotech Stock Performance In 2005
- Richard Ramko Discusses Trend In Corporate Alliances Among Biotech Companies In 2005
- Richard Ramko Discusses M&A Activity Among Biotech Firms In 2005
- Richard Ramko Discusses R&D Expenditures In Biotech Industry In 2005
- Richard Ramko States Losses In Biotech Sector Have Decreased
- Richard Ramko States Product Approval In Biotech Is Increasing
- Richard Ramko Shares Thoughts On Biotech Firms Choosing To Go Public
- Richard Ramko Shares Reasoning For Increasing Alliances Within Biotech Sector
- William Weldon Discusses Differences In Pharmaceutical and Consumer Businesses
